Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04721145 · ClinicalTrials.gov registry record · NA
CGM Use in Poorly Controlled Youth With Type 1 Diabetes
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04721145: Completed NA study, sponsored by Johns Hopkins University.
NCT04721145 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04721145, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptake of personal CGM use, and improves short-term time in range glucose control.
Interventions
- DEVICE Dexcom G6 Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2022-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04721145
The ClinicalTrials.gov registry entry for NCT04721145 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G6 Continuous Glucose Monitor is the first listed.
NCT04721145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04721145 about?
NCT04721145 is a clinical study titled "CGM Use in Poorly Controlled Youth With Type 1 Diabetes". The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in high risk, poorly controlled pediatric Type 1 diabetes patients increases uptake of personal CGM use, and improves short-term time in range glucose control.
What is the current status of trial NCT04721145?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2021-01-25. Estimated completion is 2022-06-28.
What interventions are being tested in trial NCT04721145?
The interventions under investigation include: Dexcom G6 Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT04721145?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.